vs
Childrens Place, Inc.（PLCE）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Childrens Place, Inc.的1.8倍（$622.0M vs $339.5M），Royalty Pharma plc净利率更高（34.4% vs -1.3%，领先35.7%），Royalty Pharma plc同比增速更快（4.8% vs -13.0%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -13.6%）
Children’s Place是专业儿童服饰零售商，产品主要以旗下自有品牌发售，涵盖Gymboree、Sugar & Jade、PJ Place、Crazy 8等。目前该品牌在美国、加拿大、波多黎各共开设约525家门店，同时通过两个线上渠道以及15个国家的5家加盟合作伙伴开展销售，产品涵盖上衣、裙装、鞋履、裤装、睡衣、背包等全品类儿童服饰配件。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PLCE vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.8倍
$339.5M
营收增速更快
RPRX
高出17.8%
-13.0%
净利率更高
RPRX
高出35.7%
-1.3%
两年增速更快
RPRX
近两年复合增速
-13.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $339.5M | $622.0M |
| 净利润 | $-4.3M | $214.2M |
| 毛利率 | 33.1% | — |
| 营业利润率 | 1.1% | 62.4% |
| 净利率 | -1.3% | 34.4% |
| 营收同比 | -13.0% | 4.8% |
| 净利润同比 | -121.5% | 2.9% |
| 每股收益（稀释后） | $-0.19 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLCERPRX
| Q4 25 | $339.5M | $622.0M | ||
| Q3 25 | $298.0M | $609.3M | ||
| Q2 25 | $242.1M | $578.7M | ||
| Q1 25 | $408.6M | $568.2M | ||
| Q4 24 | $390.2M | $593.6M | ||
| Q3 24 | $319.7M | $564.7M | ||
| Q2 24 | $267.9M | $537.3M | ||
| Q1 24 | $455.0M | $568.0M |
净利润PLCERPRX
| Q4 25 | $-4.3M | $214.2M | ||
| Q3 25 | $-5.4M | $288.2M | ||
| Q2 25 | $-34.0M | $30.2M | ||
| Q1 25 | $-8.0M | $238.3M | ||
| Q4 24 | $20.1M | $208.2M | ||
| Q3 24 | $-32.1M | $544.0M | ||
| Q2 24 | $-37.8M | $102.0M | ||
| Q1 24 | $-128.8M | $4.8M |
毛利率PLCERPRX
| Q4 25 | 33.1% | — | ||
| Q3 25 | 34.0% | — | ||
| Q2 25 | 29.2% | — | ||
| Q1 25 | 28.5% | — | ||
| Q4 24 | 35.5% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 34.6% | — | ||
| Q1 24 | 21.8% | — |
营业利润率PLCERPRX
| Q4 25 | 1.1% | 62.4% | ||
| Q3 25 | 1.4% | 70.1% | ||
| Q2 25 | -10.0% | 36.3% | ||
| Q1 25 | 1.7% | 94.0% | ||
| Q4 24 | 7.5% | 60.9% | ||
| Q3 24 | -6.8% | — | ||
| Q2 24 | -10.4% | 50.2% | ||
| Q1 24 | -13.6% | -13.0% |
净利率PLCERPRX
| Q4 25 | -1.3% | 34.4% | ||
| Q3 25 | -1.8% | 47.3% | ||
| Q2 25 | -14.1% | 5.2% | ||
| Q1 25 | -2.0% | 41.9% | ||
| Q4 24 | 5.1% | 35.1% | ||
| Q3 24 | -10.0% | 96.3% | ||
| Q2 24 | -14.1% | 19.0% | ||
| Q1 24 | -28.3% | 0.8% |
每股收益（稀释后）PLCERPRX
| Q4 25 | $-0.19 | $0.49 | ||
| Q3 25 | $-0.24 | $0.67 | ||
| Q2 25 | $-1.57 | $0.07 | ||
| Q1 25 | $-0.60 | $0.55 | ||
| Q4 24 | $1.57 | $0.46 | ||
| Q3 24 | $-2.51 | $1.21 | ||
| Q2 24 | $-2.98 | $0.23 | ||
| Q1 24 | $-10.24 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.3M | $618.7M |
| 总债务越低越好 | $107.4M | $9.0B |
| 股东权益账面价值 | $-8.6M | $9.7B |
| 总资产 | $762.5M | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PLCERPRX
| Q4 25 | $7.3M | $618.7M | ||
| Q3 25 | $7.8M | $938.9M | ||
| Q2 25 | $5.7M | $631.9M | ||
| Q1 25 | $5.3M | $1.1B | ||
| Q4 24 | $5.7M | $929.0M | ||
| Q3 24 | $9.6M | $950.1M | ||
| Q2 24 | $13.0M | $1.8B | ||
| Q1 24 | $13.6M | $843.0M |
总债务PLCERPRX
| Q4 25 | $107.4M | $9.0B | ||
| Q3 25 | $107.2M | $8.9B | ||
| Q2 25 | $107.0M | $8.0B | ||
| Q1 25 | $166.0M | $7.6B | ||
| Q4 24 | $165.7M | $7.6B | ||
| Q3 24 | $165.4M | $7.6B | ||
| Q2 24 | $166.6M | $7.6B | ||
| Q1 24 | $49.8M | $6.1B |
股东权益PLCERPRX
| Q4 25 | $-8.6M | $9.7B | ||
| Q3 25 | $-4.9M | $9.6B | ||
| Q2 25 | $1.4M | $9.5B | ||
| Q1 25 | $-59.4M | $9.8B | ||
| Q4 24 | $-49.6M | $10.3B | ||
| Q3 24 | $-68.9M | $10.3B | ||
| Q2 24 | $-34.9M | $9.8B | ||
| Q1 24 | $-9.0M | $9.9B |
总资产PLCERPRX
| Q4 25 | $762.5M | $19.6B | ||
| Q3 25 | $805.1M | $19.3B | ||
| Q2 25 | $779.6M | $18.3B | ||
| Q1 25 | $747.6M | $17.6B | ||
| Q4 24 | $888.8M | $18.2B | ||
| Q3 24 | $921.4M | $18.0B | ||
| Q2 24 | $848.3M | $17.7B | ||
| Q1 24 | $800.3M | $16.1B |
负债/权益比PLCERPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | 75.63× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-3.4M | — |
| 自由现金流率自由现金流/营收 | -1.0% | — |
| 资本支出强度资本支出/营收 | 2.8% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $39.5M | — |
8季度趋势，按日历期对齐
经营现金流PLCERPRX
| Q4 25 | $6.2M | $827.1M | ||
| Q3 25 | $-30.5M | $702.6M | ||
| Q2 25 | $-43.0M | $364.0M | ||
| Q1 25 | $121.3M | $596.1M | ||
| Q4 24 | $-44.2M | $742.5M | ||
| Q3 24 | $-83.9M | $703.6M | ||
| Q2 24 | $-110.8M | $658.2M | ||
| Q1 24 | $135.4M | $664.6M |
自由现金流PLCERPRX
| Q4 25 | $-3.4M | — | ||
| Q3 25 | $-31.9M | — | ||
| Q2 25 | $-46.4M | — | ||
| Q1 25 | $121.2M | — | ||
| Q4 24 | $-47.7M | — | ||
| Q3 24 | $-91.7M | — | ||
| Q2 24 | $-115.5M | — | ||
| Q1 24 | $132.2M | — |
自由现金流率PLCERPRX
| Q4 25 | -1.0% | — | ||
| Q3 25 | -10.7% | — | ||
| Q2 25 | -19.2% | — | ||
| Q1 25 | 29.7% | — | ||
| Q4 24 | -12.2% | — | ||
| Q3 24 | -28.7% | — | ||
| Q2 24 | -43.1% | — | ||
| Q1 24 | 29.1% | — |
资本支出强度PLCERPRX
| Q4 25 | 2.8% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 0.7% | — |
现金转化率PLCERPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | -2.20× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLCE
| The Childrens Place US | $307.4M | 91% |
| The Childrens Place International | $32.1M | 9% |
| Gift Cards | $1.7M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
